Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00668
|
|||||
Drug Name |
Nisoldipine
|
|||||
Synonyms |
(+-)-Isobutyl methyl 1,4-dihydro-2,6-dimethyl-4-(o-nitrophenyl)-3,5-pyridinedicarboxylate; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-, methyl 2-methylpropyl ester; 3-O-methyl 5-O-(2-methylpropyl) 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; Bay k 5552; Bay-k-5552; Baymycard; Isobutyl 1,4-dihydro-5-methoxycarbonyl-2,6-dimethyl-4-(2-nitrophenyl)-3-pyridincarboxylat;Methyl 2-methylpropyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; Nisocor; Nisoldipin; Nisoldipine (JAN/USAN/INN); Nisoldipine [USAN:BAN:INN:JAN]; Nisoldipino; Nisoldipino [INN-Spanish]; Nisoldipinum; Nisoldipinum [INN-Latin]; Sular; Sular (TN); Syscor; Zadipina
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | High blood pressure [ICD11: BA00] | Approved | [1] | |||
Therapeutic Class |
Antihypertensive Agents
|
|||||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C20H24N2O6
|
|||||
Canonical SMILES |
CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
|
|||||
InChI |
InChI=1S/C20H24N2O6/c1-11(2)10-28-20(24)17-13(4)21-12(3)16(19(23)27-5)18(17)14-8-6-7-9-15(14)22(25)26/h6-9,11,18,21H,10H2,1-5H3
|
|||||
InChIKey |
VKQFCGNPDRICFG-UHFFFAOYSA-N
|
|||||
CAS Number |
CAS 63675-72-9
|
|||||
Pharmaceutical Properties | Molecular Weight | 388.4 | Topological Polar Surface Area | 110 | ||
Heavy Atom Count | 28 | Rotatable Bond Count | 7 | |||
Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 7 | |||
XLogP |
3.3
|
|||||
PubChem CID | ||||||
PubChem SID |
103219831
, 103680984
, 104306583
, 11528722
, 117875317
, 118048486
, 12012773
, 121363368
, 124658895
, 124799896
, 125355226
, 126630843
, 126657331
, 126665640
, 131322121
, 131846259
, 134337886
, 135004762
, 135650722
, 135692260
, 137122027
, 137349418
, 139157574
, 14780577
, 26719878
, 26758055
, 29223593
, 46386699
, 46504546
, 48416330
, 49681768
, 5054384
, 53787999
, 56313694
, 56463094
, 57322301
, 6595685
, 6951250
, 7594280
, 7847684
, 7980129
, 80626920
, 81092916
, 8152772
, 92307945
, 92308528
, 92308896
, 92711446
, 93166842
, 9901
|
|||||
ChEBI ID |
CHEBI:76917
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
References | ||||||
1 | Nisoldipine was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
2 | Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade. Cancer Lett. 2016 Jan 1;370(1):153-64. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.